Find More Contacts for PregLem
Protected Content
Director Operations
2 emails found
View contacts for PregLem to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@preglem.com
  • Phone Number 41 22 884 03 40
PregLem is a Swiss based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women's reproductive medicine.

Lists Featuring This Company

Health Care Companies that Exited (Top 10K)
9,989 Number of Organizations • $791.6B Total Funding Amount • 22,478 Number of Investors
Switzerland Companies (Top 10K)
9,386 Number of Organizations • $92.9B Total Funding Amount • 7,989 Number of Investors
Private Switzerland Companies (Top 10K)
9,208 Number of Organizations • $57.9B Total Funding Amount • 7,633 Number of Investors
Europe, Middle East, and Africa (EMEA) Medical Acquired Companies
905 Number of Organizations • $7.8B Total Funding Amount • 978 Number of Investors
PregLem was acquired by Richter Group for $461M on Oct 7, 2010.

Frequently Asked Questions

Where is PregLem's headquarters? PregLem is located in Geneva, Geneve, Switzerland.Who invested in PregLem? PregLem has 4 investors including MVM Life Science Partners and Sofinnova Partners.How much funding has PregLem raised to date? PregLem has raised .When was the last funding round for PregLem? PregLem closed its last funding round on Dec 4, 2007 from a Series B round.Who are PregLem's competitors? Alternatives and possible competitors to PregLem may include ACT BiotechInion, and York Pharma.